Ouro Medicines Ltd
16049297
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Previously known as
Compliance
Last accounts
31/12/2025
total exemption full
Next accounts due
30/09/2027
Confirmation statement
Last: 28/10/2025
Due 11/11/2026
Industry
Officers
Former
director · Resigned 03/06/2026
corporate secretary · Resigned 22/06/2026
Persons with Significant Control
Gilead Sciences, Inc.
Reg: 2129876 · Delaware Division Of Corporations · Corporate
Notified 03/06/2026
Former PSCs
Jaideep Sunil Dudani
Ceased 03/06/2026
Change History
Active
Private Limited Company
3RD FLOOR
ALTRINCHAM
WA14 2DT
CompanyRankvs 7965+ SIC 72190 peers30
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
-£1.7M
Balance sheet strength
Cash
£3.8M
Cash in the bank
Net Current Assets
-£1.7M
Working capital
Current Assets
£5.0M
Current Liabilities
£6.7M
Debtors
£30k
Profit After Tax
-£36.7M
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | 0.74 |
Derived from filed accounts. Not audited figures.